Incremental value of renal function in risk prediction with the Seattle Heart Failure Model

被引:44
作者
Giamouzis, Grigorios [1 ]
Kalogeropoulos, Andreas P. [1 ]
Georgiopoulou, Vasiliki V. [1 ]
Agha, Syed A. [1 ]
Rashad, Mohammad A. [1 ]
Laskar, Sonjoy R. [1 ]
Smith, Andrew L. [1 ]
Butler, Javed [1 ]
机构
[1] Emory Univ, Ctr Heart Failure Therapy, Atlanta, GA 30322 USA
关键词
GLOMERULAR-FILTRATION-RATE; CHRONIC KIDNEY-DISEASE; BLOOD UREA NITROGEN; LONG-TERM SURVIVAL; CARDIOVASCULAR EVENTS; SYSTOLIC DYSFUNCTION; CREATININE CLEARANCE; SERUM CREATININE; PROGNOSTIC VALUE; MORTALITY;
D O I
10.1016/j.ahj.2008.10.007
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background Impaired renal function portends poor heart failure (HF) outcomes. The Seattle Heart Failure Score (SHFS), a multimarker risk assessment tool, however does not incorporate renal function. In this study, we assessed the incremental value of renal function over the SHFS in patients with advanced HF on contemporary optimal treatment. Methods Blood urea nitrogen (BUN), serum creatinine (sCr), BUN/sCr ratio, and estimated glomerular filtration rate were assessed in survival models with SHFS as the base model among 443 patients with HF (52 +/- 12 years, male 68.5%, white 52.4%, ejection fraction 0.18 +/- 0.08). Incremental value of renal function was assessed by changes in the likelihood ratio X 2 and the area under the receiver operating characteristic curves for 1-, 2-, and 3-year event prediction. Results During a median follow-up of 21 months, 108 (24.5%) of 443 patients had an event (death [n = 92], urgent transplantation In = 13], or ventricular assist device implantation In = 3]). All renal parameters individually were associated with outcome (BUN, P <.001; sCr, P <.001; BUN/sCr ratio, P =.006; and estimated glomerular filtration rate, P =.006); however, only BUN was an independent predictor of events in multivariable analyses. Addition of BUN improved the predictive ability of SHFS (Delta likelihood ratio X-2 5.03, P =.025); however, the increase in the area under the receiver operating characteristic curve was marginal (year 1, 0.786 to 0.791; year 2, 0.732 to 0.741; year 3, 0.745 to 0.754; all P >.2). Conclusion Among the various renal function parameters, BUN had the strongest association with outcomes in patients with advanced HE However, the incremental value of renal function over the SHFS for risk determination was marginal. (Am Heart J 2009;157:299-305.)
引用
收藏
页码:299 / 305
页数:7
相关论文
共 44 条
[1]   Chronic kidney disease associated mortality in diastolic versus systolic heart failure: A propensity matched study [J].
Ahmed, Ali ;
Rich, Michael W. ;
Sanders, Paul W. ;
Perry, Gilbert J. ;
Bakris, George L. ;
Zile, Michael R. ;
Love, Thomas E. ;
Aban, Inmaculada B. ;
Shlipak, Michael G. .
AMERICAN JOURNAL OF CARDIOLOGY, 2007, 99 (03) :393-398
[2]   Prevalence and significance of unrecognized renal insufficiency in patients with heart failure [J].
Amsalem, Yoram ;
Garty, Moshe ;
Schwartz, Roseline ;
Sandach, Amir ;
Behar, Solomon ;
Caspi, Abraham ;
Gottlieb, Shmuel ;
Ezra, David ;
Lewis, Basil S. ;
Leor, Jonathan .
EUROPEAN HEART JOURNAL, 2008, 29 (08) :1029-1036
[3]   Quantifying the heart failure epidemic: prevalence, incidence rate, lifetime risk and prognosis of heart failure - The Rotterdam Study [J].
Bleumink, GS ;
Knetsch, AM ;
Sturkenboom, MCJM ;
Straus, SMJM ;
Hofman, A ;
Deckers, JW ;
Witteman, JCM ;
Stricker, BHC .
EUROPEAN HEART JOURNAL, 2004, 25 (18) :1614-1619
[4]   Relationship between heart failure treatment and development of worsening renal function among hospitalized patients [J].
Butler, J ;
Forman, DE ;
Abraham, WT ;
Gottlieb, SS ;
Loh, E ;
Massie, BM ;
O'Connor, CM ;
Rich, MW ;
Stevenson, LW ;
Wang, YF ;
Young, JB ;
Krumholz, HM .
AMERICAN HEART JOURNAL, 2004, 147 (02) :331-338
[5]   Relation of blood urea nitrogen to long-term mortality in patients with heart failure [J].
Cauthen, Clay A. ;
Lipinski, Michael J. ;
Abbate, Antonio ;
Appleton, Darryn ;
Nusca, Annunziata ;
Varma, Amit ;
Goudreau, Evelyne ;
Cowley, Michael J. ;
Vetrovec, George W. .
AMERICAN JOURNAL OF CARDIOLOGY, 2008, 101 (11) :1643-1647
[6]   PREDICTION OF CREATININE CLEARANCE FROM SERUM CREATININE [J].
COCKCROFT, DW ;
GAULT, MH .
NEPHRON, 1976, 16 (01) :31-41
[7]   Rationale and design of the Valsartan Heart Failure Trial: A large multinational trial to assess the effects of valsartan, an angiotensin-receptor blocker, on morbidity and mortality in chronic congestive heart failure [J].
Cohn, JN ;
Tognoni, G ;
Glazer, RD ;
Spormann, D ;
Hester, A .
JOURNAL OF CARDIAC FAILURE, 1999, 5 (02) :155-160
[8]   Prevalence and impact of worsening renal function in patients hospitalized with decompensated heart failure: results of the prospective outcomes study in heart failure (POSH) [J].
Cowie, MR ;
Komajda, M ;
Murray-Thomas, T ;
Underwood, J ;
Ticho, B .
EUROPEAN HEART JOURNAL, 2006, 27 (10) :1216-1222
[9]   The prognostic implications of renal insufficiency in asymptomatic and symptomatic patients with left ventricular systolic dysfunction [J].
Dries, DL ;
Exner, DV ;
Domanski, MJ ;
Greenberg, B ;
Stevenson, LW .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2000, 35 (03) :681-689
[10]   Usefulness of anemia as a predictor of death and rehospitalization in patients with decompensated heart failure [J].
Felker, GM ;
Gattis, WA ;
Leimberger, JD ;
Adams, KF ;
Cuffe, MS ;
Gheorghiade, M ;
O'Connor, CM .
AMERICAN JOURNAL OF CARDIOLOGY, 2003, 92 (05) :625-628